CoChat
Sign Up
Cited by 80

The DOI matches its Crossref record.

Assessment of Cellular Proliferation in Tumors by PET Using 18F-ISO-1

Dehdashti, Farrokh, Laforest, Richard, Gao, Feng, Shoghi, Kooresh I., Aft, Rebecca L., Nussenbaum, Brian, Kreisel, Friederike H., Bartlett, Nancy L., Cashen, Amanda, Wagner-Johnson, Nina, Mach, Robert H.·2013·Journal of Nuclear Medicine
DOI 10.2967/jnumed.112.111948PMC PMC3694753
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2967/jnumed.112.111948

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PET imaging studies with [18F]ISO-1 show a strong correlation between radiotracer uptake and σ2R density in a murine breast cancer model, and an excellent correlation between radiotracer uptake and Ki-67 score in patients with lymphoma, breast, and head & neck cancer.

    “PET imaging studies with a σ2R -selective radiotracer, [18F]ISO-1, have shown a strong correlation between radiotracer uptake and the density of σ2R in a murine model of breast cancer30, and an excellent correlation between radiotracer uptake and Ki-67 score in a mixed population of patients diagnosed with lymphoma, breast, and head & neck cancer31.”

    From Sigma-2 Receptor/TMEM97 and PGRMC-1 Increase the Rate of Internalization of LDL by LDL Receptor through the Formation of a Ternary Complex (2018) · cites this paper as [31]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 30

  1. Beresford MJ Wilson GD Makris A . Measuring proliferation in breast cancer: practicalities and applications. Breast Cancer Res. 2006;8:216. · DOI
  2. 10.1038/nrc2256 · DOI
  3. 10.1038/3337 · DOI
  4. 10.1007/s00259-001-0675-3 · DOI
  5. Shields, 2003, PET imaging with 18F-FLT and thymidine analogs: promise and pitfalls, J Nucl Med., 44, 1432
  6. 10.1053/j.semnuclmed.2007.08.004 · DOI
  7. 10.1016/j.cpet.2009.04.012 · DOI
  8. 10.1021/jm0614883 · DOI
  9. 10.1016/S0046-8177(99)90062-X · DOI
  10. 10.1038/jcbfm.1990.127 · DOI
  11. 10.1097/00004647-199609000-00008 · DOI
  12. 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9 · DOI
  13. 10.1136/gut.52.11.1602 · DOI
  14. 10.2967/jnumed.107.046391 · DOI
  15. 10.1158/1078-0432.CCR-03-0040 · DOI
  16. 10.1007/s00259-007-0449-7 · DOI
  17. 10.1378/chest.129.2.393 · DOI
  18. Vesselle, 2002, In vivo validation of 3′deoxy-3′-[18F]fluorothymidine ([18F]FLT) as a proliferation imaging tracer in humans: correlation of [18F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors, Clin Cancer Res., 8, 3315
  19. 10.2967/jnumed.111.089482 · DOI
  20. 10.1007/s00259-008-0970-3 · DOI
  21. Schwartz, 2003, Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs, J Nucl Med., 44, 2027
  22. 10.1007/s00259-007-0679-8 · DOI
  23. Caveliers, 2002, Sigma receptor scintigraphy with N-[2-(1′-piperidinyl)ethyl]-3-123I-iodo-4-methoxybenzamide of patients with suspected primary breast cancer: first clinical results, J Nucl Med., 43, 1647
  24. van Waarde, 2004, Tumor imaging with 2 sigma-receptor ligands, 18F-FE-SA5845 and 11C-SA4503: a feasibility study, J Nucl Med., 45, 1939
  25. 10.1016/S0969-8051(01)00201-3 · DOI
  26. Bem, 1991, Overexpression of sigma receptors in nonneural human tumors, Cancer Res., 51, 6558
  27. 10.1016/0922-4106(93)90029-9 · DOI
  28. Vilner, 1995, Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines, Cancer Res., 55, 408
  29. 10.1158/0008-5472.CAN-03-2329 · DOI
  30. Mach, 1997, Sigma 2 receptors as potential biomarkers of proliferation in breast cancer, Cancer Res., 57, 156

Cited by

Sorted by citations

Metadata

Authors
Dehdashti, F., Laforest, R., Gao, F., Shoghi, K. I., Aft, R. L., Nussenbaum, B., Kreisel, F. H., Bartlett, N. L., Cashen, A., Wagner-Johnson, N., & Mach, R. H.
Venue
Journal of Nuclear Medicine
Publisher
Society of Nuclear Medicine
Published
2013-01-28
Volume
54
Issue
3
Pages
350-357
ISSN
  • 0161-5505
  • 2159-662X
DOI
10.2967/jnumed.112.111948
PMC
PMC3694753
Cited by
80
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review